SMS Lifesciences India Limited (NSE:SMSLIFE)

Market Cap	3.96B
Revenue (ttm)	3.46B
Net Income (ttm)	230.40M
Shares Out	3.02M
EPS (ttm)	76.19
PE Ratio	17.20
Forward PE	n/a
Dividend	1.50 (0.11%)
Ex-Dividend Date	Sep 23, 2024

Volume	1,821
Average Volume	5,087
Open	1,340.60
Previous Close	1,325.20
Day's Range	1,296.10 - 1,383.90
52-Week Range	626.45 - 1,749.65
Beta	0.42
RSI	51.27
Earnings Date	May 27, 2025

About SMS Lifesciences India

SMS Lifesciences India Limited manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India. The company offers APIs in various therapeutic areas, such as anti ulcer, erectile dysfunction, anti gout, anesthesia, anti infective, anti obesity, antifungal, anti convulsant, anti emetic, ophthalmic, anti worm, and antiemetic. It is also developing APIs in the areas of anti depressant, anti psychotic, anti hypertension, veterinary, antiviral, and anticoagulant. In addition, the company offers intermediates in the anti ul...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1990
• Employees: 574
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: SMSLIFE

Financial Performance

In 2023, SMS Lifesciences India's revenue was 3.06 billion, a decrease of -3.04% compared to the previous year's 3.16 billion. Earnings were 90.93 million, a decrease of -20.68%.